Pfizer's Bourla Sinks His Pension Into Company Stock as CEO Defends Drug Firm

DAVOS, Switzerland—Albert Bourla has ambitious plans to turn around the situation at Pfizer. The market will decide if talk is cheap, but at least for now the stock looks cheap, or so the biopharma CEO wants investors to believe. And he put his money where his mouth is. ...